ASP Isotopes (ASPI) Common Equity (2021 - 2026)

ASP Isotopes' Common Equity history runs 6 years deep, the most recent figure standing at $289.0 million for Q1 2026.

• On a quarterly basis, Common Equity rose 531.99% year-over-year to $289.0 million in Q1 2026; TTM through Mar 2026 was $289.0 million, a 531.99% increase from a year earlier, with the FY2025 full-year figure at $262.9 million, up 413.8% from the prior year.
• Common Equity climbed to $289.0 million in Q1 2026 per ASPI's latest filing, from $262.9 million in the prior quarter.
• Across five years, Common Equity topped out at $289.0 million in Q1 2026 and bottomed at $6.3 million in Q3 2022.
• The 5-year median for Common Equity is $14.4 million (2024), against an average of $53.0 million.
• Across the five-year window, Common Equity grew 9.36% in 2024 and surged 531.99% in 2026, its largest moves.
• Year by year, Common Equity stood at $9.8 million in 2022, then surged by 91.81% to $18.8 million in 2023, then jumped by 171.72% to $51.2 million in 2024, then jumped by 413.8% to $262.9 million in 2025, then climbed by 9.93% to $289.0 million in 2026.
• Per Business Quant, the three latest ASPI Common Equity figures stand at $289.0 million (Q1 2026), $262.9 million (Q4 2025), and $74.1 million (Q3 2025).